HOME >> BIOLOGY >> NEWS
A Common Microbe Could Help To Trigger Alzheimers

Could A Simple Course Of Antibiotics Protect You From Alzheimer's Disease?

A COMMON microbe could help to trigger Alzheimer's disease, say researchers in the US. If true, their controversial claim could turn the multimillion-dollar field of Alzheimer's research on its head and force a rethink on how to prevent the disease.

The microbe in question is Chlamydia pneumoniae, which is spread by coughs and sneezes. By the age of 20, half the population have been infected with C. pneumoniae, and the likelihood of being infected increases with age. The bacterium has already been accused of triggering atherosclerosis-blocked arteries that can lead to heart attacks ("Can you catch a heart attack?", New Scientist, 8 June 1996, p 38).

Alan Hudson at Wayne State University in Detroit and his colleagues did postmortems on the brains of 19 Alzheimer's patients and 19 people of the same age who had died of other causes. They found signs of C. pneumoniae in 17 of the Alzheimer's sufferers, in the hippocampus and temporal cortex. These are the parts of the brain which usually sustain most damage in Alzheimer's disease. Unaffected areas of the brain were much less likely to harbour the bacterium. The bacterium turned up in the brain of only one of the non-Alzheimer's patients.

The team also managed to culture the microbe from two of the affected brains, showing that the organism was still alive rather than a long-dead bystander (Medical Microbiology and Immunology, vol 187, p 23).

C. pneumoniae's presence in the diseased brains does not mean that it cause Alzheimer's, the scientists stress. But they think the bacterium may at least be a risk factor. Chlamydia bacteria do cause inflammation when they attack other parts of the body. And the brains of people with Alzheimer's are inflamed and contain high levels of messenger chemicals called cytokines, which trigger inflammation.

Hudson says the ba
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44 171 331 2751
New Scientist
12-Aug-1998


Page: 1 2

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Common Microbe Could Help Trigger Alzheimers

(Date:6/18/2013)... Arlington environmental engineer has been awarded a $394,300 ... ensure water quality and flow in the new ... Andrew Kruzic, UT Arlington associate professor of civil ... to add monochloramine to the water in an ... pump stations and pipelines. Adding monochloramine is widely ...
(Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
(Date:6/18/2013)... 10% of breast and ovarian cancers are familial in ... attributable to inherited mutations from the parents in genes ... mutations, PARP inhibitors, which are currently in clinical trials, ... option for personalised cancer treatment, an alternative to standard ... of these patients generate resistance to the drug and, ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 India’s ... business can potentially be worth up to a ... opportunity, the Indian government is taking serious action ... the process. , This presentation will examine:, ... regulations ,     Immediate and long term impacts ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to publish ... sulfur in ultra-low sulfur diesel (ULSD) using the new ... . The analysis detailed in Rigaku Application Note 1272 ... International Standard specifies an energy dispersive X-ray fluorescence (EDXRF) ... automotive gasoline. , Regulations around the world have limited ...
(Date:6/19/2013)... A new look at “big glass” and visionary ... highlight technical sessions at SPIE Photomask Technology 2013 ... year, the three-day event is the industry’s largest mask ... 100 technical presentations and numerous networking lunches and receptions. ... and photonics , the meeting will be held at ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of ... it has received Class III medical device license approval ... DrugCheck® NxStep Onsite Drug Screen Cup in Canada. ... device in near-patient settings, such as physicians’ offices. , ... Canada Class III approval for 24 different drugs and ...
Breaking Biology Technology:Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
Cached News: